2.07 (1.29-3.33) Q3 vs Q1 3 genes Ptrend:0.27 121/ methylated per 5 kg/m2 1.34 (1.07-1.67) 1.39 (0.88-2.19) Q33 vs Q31 Igfbp 0 genes Ptrend:0.16 112/ methylated per 5 kg/m2 1.26 (0.93-1.71) Q3 vs Q1 1.30 (1.09-1.54) 1 142/ Incidence, 56 064 cancer per 5 kg/m2 1.14 (1.03-1.26) 21.65-24 vs Life Span Study, Incidence, colon 1.16 (0.92-1.46) Semmens, 2013 Sex, city Participants are < 19.63 kg/m2 Prospective 577/ cancer, COL40929 Cancer registry Self-reported Age, attained atomic bomb Cohort, women per 5 kg/m2 1.07 (0.94-1.22) Japan age survivors M/W 21.64-23.71 vs Incidence, colon 1.46 (1.14-1.88) < 19.74 kg/m2 565/ cancer, men per 5 kg/m2 1.25 (1.07-1.45) Prospective Age, sex, van Kruijsdijk Cohort, alcohol 71/ RC, 2013 Age: 18-80 Height and Incidence, consumption, Participants are 6 172 Cancer registry per 4 kg/m2 0.96 (0.76-1.22) COL40974 years, weight measured colorectal cancer smoking status, CVD patients 6 years Netherlands M/W, pack years of High Risk smoking population
121/ 3 genes methylated Q3 vs Q1 2.07 (1.29-3.33) Ptrend:0.27 per 5 kg/m2 1.34 (1.07-1.67) 112/ Igfbp 0 genes methylated Q33 vs Q31 1.39 (0.88-2.19) Ptrend:0.16 per 5 kg/m2 1.26 (0.93-1.71) Semmens, 2013 COL40929 Japan Life Span Study, Prospective Cohort, M/W 1 142/ 56 064 Cancer registry Self-reported Incidence, cancer Q3 vs Q1 1.30 (1.09-1.54) Sex, city Age, attained age Participants are atomic bomb survivors per 5 kg/m2 1.14 (1.03-1.26) 577/ Incidence, colon cancer, women 21.65-24 vs < 19.63 kg/m2 1.16 (0.92-1.46) per 5 kg/m2 1.07 (0.94-1.22) 565/ Incidence, colon cancer, men 21.64-23.71 vs < 19.74 kg/m2 1.46 (1.14-1.88) per 5 kg/m2 1.25 (1.07-1.45) van Kruijsdijk RC, 2013 COL40974 Netherlands Prospective Cohort, Age: 18-80 years, M/W, High Risk population 71/ 6 172 6 years Cancer registry Height and weight measured Incidence, colorectal cancer per 4 kg/m2 0.96 (0.76-1.22) Age, sex, alcohol consumption, smoking status, pack years of smoking Participants are CVD patients
CUP_colorectal_SLR_2016_RO.docx